icon Healthcare, Pharmaceutical & Biotechnology

M&A in the Healthcare, Pharmaceutical & Biotech Sector

Global Healthcare spending continues to increase dramatically, at 5.4% CAGR, and expected to reach $10.059 trillion by 2022. Pharma segment is expected to reach $ 1.2 trillion worldwide by 2024. Therapeutic trends are situated in Oncology to continue to lead the way, followed by diabetes, rheumatology, and antivirals. Medtech segment forecasts to reach $595 billion by 2024. In vitro diagnostics is expected to remain the largest medtech segment (2019 Global Life Sciences Outlook, Deloitte).

While the deal volume of healthcare corporate M&A stayed relatively flat in 2018, disclosed value grew 31% over the 2017 level, to $435 billion, surpassing the 2015 peak of $432 billion. Revenue growth, fueled by acquisition, will likely become the most important driver of total shareholder return (TSR), as price-to-earnings (P/E) multiple expansion slows and pressure against rising prices intensifies.  (Global Healthcare Private Equity and Corporate M&A Report 2019, Bain Capital)

Deal activity and values were robust globally, setting post-recession highs across regions. While North America continued to account for the most deals and highest values, the European and Asia-Pacific regions reached historically high levels in value. Key sectors driving the healthcare industry in the forecast include provider and related services, biopharma, medtech, and software and technology solutions.

CDI Global Expertise

CDI Global has a proven track record of 80+ healthcare transactions closed by partners, including sell, buy, fund raising, and joint ventures, in all segments and across the globe. Our team members have a wide range of expertise in different segments of the healthcare space, including software & IT, medical equipment, devices, pharma and biotech, consumer health and care, diagnostics, providers, services and supplies, as well as healthcare corporate and/or consultancy experience. We provide direct access and relationships with major healthcare corporations and financial investors.

CDI Global Healthcare, Pharmaceutical & Biotech Sector Leaders

  1.  Marc De Clerck

CDI Global Healthcare, Pharmaceutical & Biotech Team Members

  1. Gianmaria Castoldi 
  2. Olivier Chantre 
  3. Thierry Gibert 
  4. Adrian Gilson
  5. Eduardo Glez-Gallarza
  6. Hervé Guyot
  7. Marc Möckli
  8. Carmelo Morenas
  9. Brent Peterson

View all transactions
Sector group leaders